Advancing Cancer Research Through Discovery, Collaboration, and Clinical Impact
Scientific discovery is central to the mission of Saint John’s Cancer Institute. Our physicians, scientists, fellows, and research teams work together to advance the understanding of cancer while translating laboratory and clinical discoveries into meaningful improvements in patient care. Many of our investigators are also practicing clinicians, bringing firsthand knowledge of patients’ needs into the research process and helping ensure that today’s discoveries inform tomorrow’s treatments.
Each year, Saint John’s Cancer Institute publishes an Annual Research Report highlighting peer-reviewed publications, scientific milestones, and collaborative achievements from across the Institute. These reports reflect the dedication of our multidisciplinary teams and provide a snapshot of the ongoing work that continues to shape cancer care both within our community and around the world.
Research Collaboration Across Specialties
The Saint John’s Cancer Institute, Santa Monica, CACancer research is rarely accomplished by a single investigator. At Saint John’s Cancer Institute, our research culture is built on collaboration among physicians, scientists, fellows, laboratory investigators, and national and international partners. Many publications represent the combined expertise of multiple researchers, with faculty members supporting one another across disease sites, specialties, and scientific disciplines.
Our research spans numerous areas of expertise, including melanoma, breast, urology, endocrine, thoracic and pulmonary, gastrointestinal (GI), gynecologic (GYN), and Translational Molecular Medicine. By combining laboratory science with clinical investigation, our teams pursue innovative approaches to cancer prevention, diagnosis, treatment, survivorship, and precision medicine.
Faculty members also mentor fellows and early-career investigators who actively contribute to research projects, publications, and scientific presentations. This collaborative environment helps develop future leaders in oncology while strengthening the Institute’s ability to answer increasingly complex questions through multidisciplinary investigation.
Annual Research Reports
Explore the annual accomplishments of Saint John’s Cancer Institute researchers through our published research reports.
2025 Annual Research Report
Saint John’s Cancer Institute 2025 Research Report – Faculty PublicationsThe 2025 report highlights 74 peer-reviewed publications produced by 34 scientists and clinicians, featuring a new Executive Summary that showcases eight significant studies representing advances across multiple areas of cancer research. The report also reflects the continued growth of the Institute’s research enterprise, including the launch of the Precision Translational Medicine Lab and ongoing expansion of multidisciplinary scientific collaboration.
Saint John’s Cancer Institute 2022 Research Report – Faculty PublicationsThe 2024 report highlights scientific collaboration across Saint John’s Cancer Institute and our national and international research partners, demonstrating how multidisciplinary investigation continues to advance translational cancer research and improve clinical care. This year’s collective achievements reflect a research community that is increasingly integrated, data‑driven, and positioned to accelerate discovery. New partnerships have broadened access to innovative technologies and strengthened the Institute’s ability to pursue high‑impact studies across multiple disease sites. Together, these efforts underscore a shared commitment to transforming scientific insight into meaningful improvements for patients and families.
Saint John’s Cancer Institute 2023 Research Report – Faculty PublicationsThe 2023 report showcases continued progress in laboratory and clinical research, highlighting faculty-led investigations, fellow participation, and collaborations that contribute to new knowledge across multiple cancer specialties. This year’s work reflects a research environment that is increasingly integrated, leveraging shared expertise to accelerate discovery across disease sites. Emerging projects demonstrate meaningful advances in biomarker development, precision oncology, and early‑phase clinical trials. These collective efforts underscore the Institute’s commitment to translating scientific innovation into improved patient outcomes.
Saint John’s Cancer Institute 2022 Research Report – Faculty PublicationsThe 2022 report documents another year of scientific discovery, reflecting the Institute’s longstanding commitment to advancing translational research and supporting collaborative efforts that improve cancer diagnosis, treatment, and patient outcomes. This year’s body of work illustrates how sustained investment in foundational science continues to open new avenues for innovation across disease sites. Faculty, fellows, and research partners contributed to projects that strengthened our understanding of tumor biology, therapeutic response, and emerging diagnostic technologies. These achievements highlight a research ecosystem that is steadily expanding its capabilities and shaping future directions in precision cancer care.
Every publication represents more than a completed study—it reflects years of scientific inquiry, collaboration, mentorship, and a shared commitment to improving the lives of patients. Whether conducted in the laboratory, the clinic, or through partnerships with institutions around the world, research at Saint John’s Cancer Institute is driven by a common purpose: transforming scientific discovery into better cancer care.
As our research programs continue to grow, so does the strength of our collaborative community. Physicians, scientists, fellows, and research professionals work together across disciplines, contributing their expertise to studies that extend far beyond a single specialty or institution. Through this continued commitment to discovery, Saint John’s Cancer Institute remains dedicated to advancing knowledge, expanding treatment possibilities, and helping shape the future of cancer care for patients locally and around the world.
